Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print HIV persists in the gut despite long-term HIV therapy

HIV persists in the gut despite long-term HIV therapy

February 14, 2008

Second study finds that B-cell abnormalities also persist

Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. One important reservoir is the gut, where HIV causes much of its damage due to the large number of HIV target cells that reside there. These cells, known as CD4+ T cells, are largely contained in lymph nodes and patches of lymphocytes that collectively are called gut-associated lymphoid tissue, or GALT.




Because of the importance of the gut to HIV disease, scientists hoped that long-term treatment with antiretroviral drugs could eradicate HIV from the GALT. A new NIAID study, published online by The Journal of Infectious Diseases, has found that this goal seems unlikely with current antiretroviral drugs.

Tae-Wook Chun, Ph.D., of the NIAID Laboratory of Immunoregulation (LIR), Anthony S. Fauci, M.D., LIR chief and NIAID director, and their colleagues intensively studied eight patients receiving effective antiretroviral therapy for up to 9.9 years. In each of these of these individuals, therapy had consistently kept their blood levels of HIV at undetectable levels. Sensitive tests, however, detected the persistence of HIV as well as lowered CD4+ T cell levels in the GALT that did not completely rebound in response to therapy. Levels of virus were higher in the GALT than in immune cells in the blood, where HIV also was consistently found. In addition, the scientists found evidence of cross infection between the GALT and the lymphocytes in the blood, suggesting that one reason the virus persists in the blood is because of ongoing cycles of replication in the GALT. The authors conclude that any possibility of further lowering or eliminating viral reservoirs likely will require more powerful drug regimens to stop the low levels of ongoing viral replication originating in the GALT. The development of such regimens is an important goal of NIAID-supported research.

A second study from the Fauci laboratory, conducted by Susan Moir, Ph.D., and her colleagues and also published online by The Journal of Infectious Diseases provides additional insights into the effects of antiretroviral therapy on the HIV disease process.

In most HIV-infected individuals, the virus replicates at high levels and CD4+ T-cell numbers decline. These two factors also strongly affect B cells, the cells of the immune system that make antibodies and help protect against infection. Dr. Moir and her colleagues demonstrated that prior to treatment with antiretroviral therapy, B-cell numbers in the blood of HIV-infected individuals who have been infected for several years are low, and the B cells also include several dysfunctional subsets. After one year of effective treatment with antiretroviral therapy, B-cell numbers returned to normal, and several of the dysfunctional subsets also normalized. However, those B-cells that provide long-term protection against infection--so-called memory B cells--did not return to normal levels. Dr. Moir notes that these findings strengthen the notion that while antiretroviral therapy improves many aspects of immune function in HIV-infected individuals, important deficiencies remain, especially in individuals who wait several years before initiating therapy. More studies are needed to determine whether early initiation of antiretroviral therapy helps restore the immune system more completely.

NIH/National Institute of Allergy and Infectious Diseases



Related Antiretroviral Therapy Current Events and Antiretroviral Therapy News Articles Antiretroviral Therapy Current Events and Antiretroviral Therapy News RSS Antiretroviral Therapy Current Events and Antiretroviral Therapy News RSS
Many pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission.

Taking medicine for HIV proves hard to swallow for many people
Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely difficult for many individuals to do.

Feelings of stigmatization may discourage HIV patients from proper care
The feeling of stigmatization that people living with HIV often experience doesn't only exact a psychological toll -new UCLA research suggests it can also lead to quantifiably negative health outcomes.

Maternal HIV-1 treatment protects against transmission to newborns
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding.

Research shows treating HIV-AIDS with interleukin-2 is ineffective
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.

Nurses safely and effectively prescribe antiretroviral drugs in pilot program
Given sufficient training and support, nurses can safely and effectively prescribe antiretroviral therapy (ART) to patients with HIV, according to a Rwandan study published in this week's PLoS Medicine.

Study finds nontuberculous mycobacteria lung disease on the rise in the United States
Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary (lung) disease in humans. Pulmonary NTM is on the rise in the United States, according to a large study of people hospitalized with the condition.

HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.

Updated Guidelines Highlight Primary Care Needs of Those Living With HIV
With HIV patients living longer thanks to advances in treatment, the primary care needs of those living with HIV have never been more important.

Protein excreted in urine may be help in diagnosing kidney disease caused by HIV
New data collected at Columbia University Medical Center and by the Mount Sinai School of Medicine are helping researchers understand the extent to which a certain protein - NGAL - can play a significant role in marking chronic kidney disease resulting from HIV while at the same time distinguishing nephropathy from more common causes such as diabetes and hypertension.
More Antiretroviral Therapy Current Events and Antiretroviral Therapy News Articles
  Take HAART: Medication adherence in the era of highly active antiretroviral therapy. (Clinical Update).: An article from: Australian Nursing Journal
by Kate Allardice (Author)

This digital document is an article from Australian Nursing Journal, published by Australian Nursing Federation on April 1, 2002. The length of the article is 2286 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Take HAART: Medication adherence in the era of highly active antiretroviral therapy. (Clinical Update).
Author: Kate Allardice
Publication: Australian Nursing Journal (Refereed)
Date: April 1, 2002
Publisher: Australian Nursing Federation
Volume: 9 Issue: 9 Page: S1(3)

Distributed by Thomson...

Early initiation of highly active antiretroviral therapies for AIDS: Dynamic choice with endogenous and exogenous learning [An article from: Journal of Health Economics]

Early initiation of highly active antiretroviral therapies for AIDS: Dynamic choice with endogenous and exogenous learning [An article from: Journal of Health Economics]
by P. Lasserre (Author), J.P. Moatti (Author), A. Soubeyran (Author)

This digital document is a journal article from Journal of Health Economics, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Criteria for initiation of highly active antiretroviral treatments (HAART) in HIV-infected patients remain a matter of debate world-wide because short-term benefits have to be balanced with costs of these therapies, and restrictions placed on future treatment options if resistant viral strains develop. On the other hand, postponing the introduction of HAART may involve a therapeutic opportunity cost if a patient's health is allowed to deteriorate to such an extent of becoming unable to benefit from new...

Models for Life: Advancing Antiretroviral Therapy in Sub-Saharan Africa--Current African Issues 31

Models for Life: Advancing Antiretroviral Therapy in Sub-Saharan Africa--Current African Issues 31
by Jeffrey V. Lazarus (Editor), Catrine Christiansen (Editor), Lise Rosendal Ostergaard (Editor), Lisa Ann Richey (Editor)

Models for Life: Advancing antiretroviral therapy in sub-Saharan Africa is based on two conferences that were held in Copenhagen and Uppsala, in September 2004. The events brought together more than 70 key actors from Denmark, Sweden, and Uganda in the field of HIV/AIDS and its treatment—antiretroviral therapy. The conferences were unique in that each panel and the subsequent discussion brought together researchers, donors, and representatives from non-governmental organizations in order to link theory, operations research, and practice.

The working paper covers a wide range of the issues that were brought up at the conferences, but focuses on the following three main topics:

o access to antiretroviral therapy;
o H\holistic approaches to providing...

Antiretroviral Therapy

Antiretroviral Therapy
b



ANTIRETROVIRAL THERAPY FOR HIV INFECTION: A Public Health Approach

ANTIRETROVIRAL THERAPY FOR HIV INFECTION: A Public Health Approach
by SIMON SENTUMBWE (Author)

The estimated number of PLWHA worldwide in 2007 (UNAIDS/WHO) was 33.2 million and of these, more than 68% are in Sub-Saharan Africa. Globally, over 5700 persons die from AIDS daily, due to inadequate access to treatment services. The objective of this book, in tandem with WHO’s public health approach to anti-retroviral therapy is to promote safe, effective, quality and rational use of antiretroviral drugs. This book articulates standard regimens for use of antiretroviral therapy for adults and adolescents; women of child-bearing potential or who are pregnant;infants and children; eligibility criteria as well as standards for monitoring and managing patients.The contents include: when to start ART; ARV regimens to start with; reasons for changing ART;regimens to use when...

  Antiretroviral therapy in HIV positive pregnant women and risk of pre-eclampsia, fetal death, preterm birth and low birthweight.(ROUND UP: Maternal Mortality ... An article from: Reproductive Health Matters
by Gale Reference Team (Author)

This digital document is an article from Reproductive Health Matters, published by Thomson Gale on November 1, 2007. The length of the article is 447 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Antiretroviral therapy in HIV positive pregnant women and risk of pre-eclampsia, fetal death, preterm birth and low birthweight.(ROUND UP: Maternal Mortality and Morbidity)(Human immunodeficiency virus)
Author: Gale Reference Team
Publication: Reproductive Health Matters (Magazine/Journal)
Date: November 1, 2007
Publisher: Thomson Gale
Volume: 15 Issue: 30 Page:...

  Racial disparities persist in HIV care, especially HAART.(Infectious Diseases)(Highly active antiretroviral therapy): An article from: Internal Medicine News
by Thomson Gale (Publisher)

This digital document is an article from Internal Medicine News, published by Thomson Gale on July 1, 2005. The length of the article is 527 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Racial disparities persist in HIV care, especially HAART.(Infectious Diseases)(Highly active antiretroviral therapy)
Publication: Internal Medicine News (Magazine/Journal)
Date: July 1, 2005
Publisher: Thomson Gale
Volume: 38 Issue: 13 Page: 62(1)

Distributed by Thomson...

  Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand (1).: An article from: Emerging Infectious Diseases
by Somsak Akksilp (Author), Opart Karnkawinpong (Author), Wanpen Wattanaamornkiat (Author), Daranee Viriyakitja (Author), Patama Monkongdee (Author), Walya Sitti (Author), Dhanida Rienthong (Author), Taweesap Siraprapasiri (Author), Charles D. Wells (Author), Jordan W. Tappero (Author), Jay K. Varma (Author)

This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on July 1, 2007. The length of the article is 5879 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand (1).
Author: Somsak Akksilp
Publication: Emerging Infectious Diseases (Magazine/Journal)
Date: July 1, 2007
Publisher: Thomson Gale
Volume: 13 Issue: 7 Page: 1001(7)

Distributed by Thomson...

Potency and vulnerability: Troubled 'selves' in the context of antiretroviral therapy [An article from: Social Science & Medicine]

Potency and vulnerability: Troubled 'selves' in the context of antiretroviral therapy [An article from: Social Science & Medicine]
by A. Persson (Author), C. Newman (Author)

This digital document is a journal article from Social Science & Medicine, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
The concepts of health and self have become intimately entangled in contemporary western society. Health is figured as a marker of identity, as a vehicle of self-production and self-actualisation, while the individual is also made increasingly responsible for his or her health. In this paper, we explore how ''self'' is constituted in discourses that shape the ways in which people understand and do health and medicine, particularly discourses of neoliberalism and of the immune system. Of interest here is how...

  Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy ... An article from: Southern Medical Journal
by Federica Faggian (Author), Massimiliano Lanzafame (Author), Emanuela Lattuada (Author), PierLuigi Brugnaro (Author), Giovanni Carretta (Author), Paolo Cadrobbi (Author), Ercole Concia (Author)

This digital document is an article from Southern Medical Journal, published by Southern Medical Association on April 1, 2004. The length of the article is 1725 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era.(Case Report)
Author: Federica Faggian
Publication: Southern Medical Journal (Refereed)
Date: April 1, 2004
Publisher: Southern Medical Association
Volume: 97 Issue: 4 Page:...

© 2009 BrightSurf.com